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Fractalkine expression and the recruitment of CX3CR1 cells The acute phase of glomerulonephritis (GN) is charac-
in the prolonged mesangial proliferative glomerulonephritis. terized by glomerular infiltration of inflammatory cells
Background. We established the reversible and the pro- and the proliferation of mesangial cells [1–8]. It has beenlonged models of mesangial proliferative glomerulonephritis
proposed that the secretary product from macrophage(GN) with anti-Thy 1 antibody 1-22-3. However, the essential
and lymphocytes plays an important role in the develop-factors leading to the prolonged glomerular alterations have
not been identified. ment of mesangial proliferative GN in both human and
Methods. The expressions of several chemokines and cyto- experimental models [1, 2, 9–12]. Thy 1.1 GN is most
kines were compared in the reversible and the prolonged mod-
commonly used as the model of mesangial proliferativeels. Expression of fractalkine and the number of the fractalkine
GN [13–16]. However, because the Thy 1.1 model is self-receptor CX3CR1-positive cells in the glomeruli in the pro-
longed model were significantly higher than those in the revers- limiting, and glomerular architecture returns to normal
ible model. Then, the localization of fractalkine and the charac- within six to eight weeks, it is not available to elucidate
teristics of CX3CR1 cells were analyzed in glomeruli. To the mechanism of the role of the inflammatory cells inelucidate the significance of the fractalkine expression, we ana-
the development of the prolonged mesangial alterations.lyzed the expression in the model treated with angiotensin II
We have previously reported that anti-Thy 1.1 mAbreceptor antagonist, candesartan.
Results. Immunostaining of fractalkine was detected on en- 1-22-3 causes severer mesangial alterations than OX-7
dothelial cells on the fifth day, and fractalkine staining also and polyclonal anti-thymocyte serum [17]. A single injec-
was detected in the mesangial area on day 14. Major parts of the
tion of mAb 1-22-3 to uninephrectomized rats causedCX3CR1 cells in the glomeruli were macrophages, especially
the prolonged mesangial alterations (prolonged model),ED3 cells. Candesartan treatment ameliorated the glomerular
morphological findings at six weeks after disease induction. although the mesangial alterations induced by an injec-
Although the treatment did not ameliorate the morphological tion of mAb 1-22-3 into rats without uninephrectomy
finding at two weeks, decreased expression of fractalkine and were reversible (reversible model) [18]. It is reportedCX3CR1 were already detected at two weeks in rats treated that uninephrectomy increased single nephron glomeru-with candesartan.
lar filtration rate (GFR) in the remaining kidney, andConclusions. Fractalkine expression and the recruitment of
CX3CR1 cells in glomeruli might play an important role in also promoted several cytokines production [19]. These
the development of the prolonged disease. These expressions alterations caused by uninephrectomy are considered to
could be predictors of the prolonged disease of the mesangial
affect the outcome of the disease, although the preciseproliferative glomerulonephritis.
mechanisms of mesangial alterations in the prolonged
model have not been fully elucidated to date.
The purpose of this study was to identify the essential
factor that causes the prolonged disease. We analyzed
the inflammatory responses in glomeruli in the earlyKey words: candesartan, ED3 cell, Thy 1.1 glomerulonephritis, in-
flammation, cell proliferation, chemokine. stage of the prolonged model and the reversible model.
We detected that fractalkine expression and the recruit-Received for publication April 10, 2001
ment of fractalkine receptor CX3CR1-positive cells inand in revised form November 27, 2001
Accepted for publication January 24, 2002 glomeruli were significantly higher in the prolonged
model than in the reversible model. Fractalkine is a novel 2002 by the International Society of Nephrology
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fourth class of chemokine that possesses three amino Induction of the uninephrectomized prolonged model
acid residues between the first and the second cysteines Sixty rats were divided into two groups: (a) thirty rats
(C-X3-C motif) [20]. Unlike other chemokines, fractal- were uninephrectomized two weeks before injection of
kine can exist in two forms, either the membrane an- 1.0 mL of saline containing 0.5 mg monoclonal antibody
chored or soluble form [21]. The soluble C-X3-C chemo- (mAb) 1-22-3; (b) thirty rats were sham operated two
kine is reported to have potent chemoattractant activity weeks before the injection of 1.0 mL of saline containing
for T cells and monocytes, and the membrane-anchored 0.5 mg mAb 1-22-3. Five rats in each group were sacri-
fractalkine, which is mainly expressed by endothelial ficed at 30 minutes, 24 hours, and 5, 14, and 56 days after
cells, promotes strong adhesion of those leukocytes. the injection of mAb 1-22-3. Five rats of each group
Feng et al recently reported that fractalkine has an essen- were sacrificed before the injection of mAb 1-22-3 as a
tial role in the crescent formation of anti-glomerular control of the baseline (0 hour). As controls, five rats
basement membrane (GBM) GN in WKY rats [22, 23]. were injected with phosphate-buffered saline (PBS) two
They suggested that fractalkine may be especially impor- weeks after the unilateral nephrectomy, and sacrificed
tant for leukocyte recruitment in tissues with a high blood on 56 days after the injection. Unilateral nephrectomy
flow rate, for example, in glomeruli, where the low-affin- and sham operations were performed under ether anes-
ity binding of other chemokines to proteoglycan may thesia. A small flank incision was made, the left renal
not withstand the high shear environment [22]. These capsule and the adrenal gland were separated from the
characteristics of fractalkine taken together with our kidney, the renal artery, vein, and ureter were ligated at
findings, we hypothesized that fractalkine plays an im- renal pedicle and the left kidney was removed. The sham
portant role in the recruitment and adhesion of inflam- operation involved the same surgical procedure, but the
matory cells in glomeruli of nephrectomized rats injected kidney and the renal pedicle were undamaged.
with mAb 1-22-3, the glomerular filtration of which was
increased. Urinary protein excretion
To elucidate the significance of the fractalkine expres- Urine was collected from the rats in a metabolic cage
sion for the development of the disease, we analyzed the
for 24 hours, and 1, 7, and 14 days after the surgery, and
expression in the model treated with angiotensin II type
1, 3, 5, 7, 14, 21, 28, 35, 42, 48, and 56 days after the
I receptor antagonist (AT1RA), candesartan. We ob-
mAb 1-22-3 or PBS injection. The amount of urinaryserved that the decreased expression of fractalkine and
protein excretion was measured by the Bradford methodCX3CR1 at two weeks in rats treated with AT1RA, (Bio-Rad, Oakland, CA, USA).although the treatment did not ameliorate the morpho-
logical finding at two weeks. We confirmed that AT1RA Morphological and immunohistochemical studies
treatment ameliorated the glomerular morphological
The right kidney of each rat was removed immediately.findings at six weeks after disease induction, suggesting
For light microscopy, part of the kidney was fixed withthat these expressions could be predictors of a prolonged
Carnoy’s solution, embedded in paraffin and a sectiondisease in course of mesangial proliferative glomerulone-
was stained with periodic acid-Schiff (PAS) and periodicphritis. This study further examined the localization of
acid-methenamine silver (PAM). Mesangial matrix ex-fractalkine expressing cell and determined the subpopu-
pansion was analyzed semiquantitatively as grades fromlation of leukocyte CX3CR1 cells. Immunofluorescence
0 to 4 according to the method of Raij, Azar and Keane(IF) studies suggested that fractalkine was expressed by
[24]. The severity of mesangiolysis at 24 hours after theendothelial cells in the early phase and also by mesangial
mAb 1-22-3 injection was scored by 0 to 4 according tocells in the late phase. Almost all CX3CR1 cells in
the method described by Johnson et al [25].glomeruli attracted by fractalkine were not T cells but
For immunofluorescence microscopy, renal tissue wasmacrophages. The major parts of CX3CR1 cells in glo-
quickly frozen in n-hexane and cooled to 70C. Four-meruli were the ED3 cells that are reported to be acti-
micrometer thick sections were cut by cryostat. These sec-vated macrophages. These results suggest that fractal-
tions were incubated with anti–-smooth muscle actinkine and CX3CR1 cells attracted by fractalkine are
(-SMA) antibody, (Sigma St. Louis, MO, USA) or anti-involved in the development of prolonged mesangial
rat collagen type I antibody (Chemicon, Temecula, CA,proliferative GN.
USA), and then stained with FITC-conjugated anti-
mouse IgG2a or FITC-conjugated anti-rabbit IgG (South-
METHODS ern Biotechnology Associates, Birmingham, AL, USA),
Animals respectively. The intensity of -SMA and collagen type
I staining was scored as the method described by FloegeSpecific pathogen free female Wistar rats (6 weeks
et al [26]. To identify the subpopulation of inflammatoryold) were purchased from Charles River Japan Inc. (At-
sugi, Japan). cells recruited in glomeruli, the cryostat sections were
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incubated with anti-leukocyte common antigen (OX-1; Kidney binding and complement fixation
Serotec, Oxford, UK), anti-PMN (RP-3; kindly donated To compare the amount of mAb 1-22-3 bound to the
by Dr. Sendo, Yamagata University, Japan), anti-pan ma- kidney, each of the three nephrectomized or sham oper-
crophage (ED1; Chemicon), anti-activated macrophage ated rats were injected with mAb 1-22-3 labeled with
(ED3; Chemicon), anti-pan T cell (OX-19; European 125I, and kidneys were removed 30 minutes after the mAb
Collection of Animal Cells, Porton Down, Salisbury, 1-22-3 injection. Monoclonal antibody 1-22-3 was labeled
UK), and then stained with FITC-conjugated anti-mouse with 125I by the chloramine-T method and the level of
IgG1 (Southern Biotechnology Associates) for OX-1, 125I bound to the kidneys was measured as described
ED1, and OX-19, or FITC conjugated anti-mouse IgG2a previously [27]. To compare the complement fixation
for ED3, or FITC conjugated anti-mouse IgM (Southern in glomeruli, 30 minutes after the injection the kidney
sections were incubated with FITC-conjugated anti-ratBiotechnology Associates) for RP-3. The number of pos-
C3 (Dako). IF intensity of 30 full sized glomeruli fromitive cells for these markers was counted in 30 full sized
the sections of five rats of each group was measuredglomeruli. The numbers were expressed as the mean
by an auto-exposure system (Vanox AHBS3; Olympus,cells per glomeruli.
Tokyo, Japan) as described previously [17].
Immunostaining of fractalkine
Semiquantitative reverse transcriptase (RT)-PCRRabbit anti-rat fractalkine antibody was purchased
Glomeruli were isolated from kidneys pooled fromfrom Torrey Pines Biolabs, Inc. (San Diego, CA, USA).
the same group. The total RNA was extracted fromTo confirm the specificity of the staining of the anti-
isolated glomeruli by TRIZOL (Gibco BRL, Gaithers-fractalkine antibody, the antibody was absorbed with the
burg, MD, USA) and stored at 70C before use. RNAfusion protein of the chemotactic site of the fractalkine
was quantified by absorbance at 260 nm. First strandof rat. Chemotactic site of rat fractalkine coding 76 amino
cDNA was synthesized by total RNA from each groupacid residues and engineered with EcoRI (5) and SalI
by using a commercial kit (Superscript preamplification(3) restriction sites so as to maintain the appropriate
system; Gibco BRL). Five micrograms of RNA was in-reading frame were amplified by polymerase chain reac-
cubated at 42C for 50 minutes in a final volume oftion (PCR), and directly subcloned with pGEX-6P-1 vec-
20 L, which contained 20 mmol/L Tris-HCl (pH 8.4),tor (Amersham Pharmacom Biotech, Buckinghamshire,
50 mmol/L KCl, 2.5 mmol/L MgCl2, 1 mmol/L each ofUK). Following bacterial transformation, cells of bacte-
dATP, dCTP, dGTP and dTTP, 0.5 mg oligo (dT) andrial culture were pelleted, washed, solubilized, and ap-
50 U reverse transcriptase (SuperScript II; Gibco BRL).plied in sodium dodecyl sulfate-polyacrylamide gel elec-
At the end of the incubation, samples were heated attrophoresis (SDS-PAGE). Fusion protein was extracted
90C for five minutes to eliminate the transcriptase activ-from acrylamide gels. As control for absorption test, the
ity. Then, 3 L of cDNA were amplified in a 50 L totalfusion protein of pGEX-6P-1 vector without insert was
volume of PCR buffer containing 10 mmol/L Tris-HCl
used. The rate of fractalkine positive glomeruli on the
(pH 8.3), 50 mmol/L KCl, 1.5 mmol/L MgCl2, 200 mmol/L14th day after mAb 1-22-3 injection was determined in each dATP, dCTP, dGTP and dTTP, 0.4 mmol/L each
randomly selected 20 full sized glomeruli. The glomeru- of the 5 and 3 primers and 2.5 U heat-activated Taq
lus in which clearly specific staining of fractalkine was DNA polymerase (AmpliTaq Gold; Perkin-Elmer, Fos-
detected over 50% area was defined as fractalkine posi- ter, CA, USA). The primers of MCP-1, RANTES,
tive glomerulus. To examine the localization of the frac- lymphotactin and GAPDH were designed according to
talkine expressing cell, dual labeling IF studies were per- published sequence [12, 28]. The primers of fractalkine,
formed with anti-fractalkine and anti-rat endothelial cell CX3CR1 and macrophage derived chemokine (MDC)
(RECA1; Serotec), or mAb 1-22-3. were designed based on their sequences. The sequences
of the primers, the sizes of PCR product expected and
Identification of CX3CR1 expressing cells annealing temperature were shown in Table 1. PCR prod-
To determine which subpopulation of leukocytes the ucts of fractalkine and CX3CR1 were sequenced and
CX3CR1 cells are located, dual-labeling studies were confirmed to be specific products of rat fractalkine and
performed. The sections were incubated with anti- rat CX3CR1. Amplification was carried out using the PC-
CX3CR1 (Torrey Pines Biolabs, Inc.) and ED1, ED3, 800 programmable temperature control system (Astec,
or OX-19, and then stained with FITC-conjugated anti- Fukuoka, Japan) through 20 to 35 cycles of denaturation
rabbit IgG and TRITC-conjugated anti-mouse IgG at 95C for 30 seconds, annealing at individual tempera-
(Dako, Glostup, Denmark). The CX3CR1 cells, and tures for 30 seconds, and extension at 72C for one mi-
double positive cells with ED1, ED3, or OX-19 were nute. The optimum number of amplification cycles used
for semiquantitative PCR was chosen based on the pre-counted in 20 full sized glomeruli.
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Table 1. Primers used in this study
Sense primer Antisense primer Temperature C Size bp
MCP-1 5-CTC TTC CTC CAC TAT GC-3 5-CTC TGT CAT ACT GGT CAC TTG-3 60 457
RANTES 5-ACC TGC CTC CCC ATA TGG CT-3 5-GTA TTC TTG AAC CCA CTT CTT CTT C-3 60 190
Lymphotactin 5-CCT GGG AGT CTG CTG CTT CG-3 5-TGG CGG ACC TCT GGG CTT GT-3 60 313
Fractalkine 5-CTC GCC AAT CCC AGT GAC CTT 5-GAT TGG TAG ACA GCA GAA CTC GGC 61 492
GCT O-3 CAA ATG-3
TARC 5-GCG TGC TGC CTG GAT TAC TTC 5-TTC TTC ACA TGT TTG TCT TTG GGG 58 154
AA-3 TC-3
MDC 5-TGG CAC TTC AGA CCT CCG 5-AGG GGA CGG ACA GGA AGT ACA-3 58 398
ATG-3
CX3CR1 5-AGC TGC TCA GGA CCT CAC 5-GTT GTG GAG GCC CTC ATG GCT GAT-3 61 319
CAT-3
GAPDH 5-CTC TAG CCA CGG CAA GTT 5-GGA TGA CCT TGC CCA CAG C-3 60 516
CAA-3
liminary trial in the linear phase of amplification. The sedimented cells on the top surface of the filter were
wiped off and migrated cells on the undersurface werePCR products were electrophoresed on 1.2% agarose
gel containing 0.0001% ethidium bromide in TAE buf- fixed in methanol for 30 seconds, and stained with Giem-
sa’s solution (Merck Japan, Tokyo, Japan). The cell num-fer, and band intensities were determined by image anal-
ysis using a Macintosh computer and the densitometry bers were counted with four filters. Results were ex-
pressed as mean SEM cell number per low power fieldsprogram, Densitograph (ATTO, Tokyo, Japan). All re-
sults were corrected for the amount of mRNA of (200). As control, PBS with 1 mg/mL BSA was placed
in the lower chamber. For the immunofluorescence (IF)GAPDH as an internal standard. The data are shown
as ratios relative to control rat expression (0 hr of the study, the migrated cells on the undersurface of the filters
were stained with ED3 and FITC anti-mouse IgG2a,sham operated group) and are expressed as mean  SD
of these independent experiments. after the sedimented cells on the top surface of the filter
were wiped off.
Real-time RT-PCR
Effect of AT1RA on the expression of fractalkineReal-time PCR was performed basically according to
and CX3CR1the manufacturer’s manual. cDNA was synthesized as
described above. cDNA, specific primers and SYBR To analyze the long-term consequence of AT1RA,
candesartan treatment, the prolonged mesangial GN wasGreen (Takara, Otsu, Japan) were mixed with Takara
Ex Taq R-PCR Version For Real Time PCR kit (Ta- induced by a single injection of 0.5 mg mAb 1-22-3 into
uninephrectomized rats. Six rats of each group were in-kara). PCR reactions were run on Smart Cycler System
(Takara). The sequences of the primers of fractalkine jected daily from day 0 (1 hour after disease induction)
through experimental period intraperitoneally with 0.5and GAPDH were described above. The reactions and
run for all samples were performed in duplicate. mg/kg body wt/day of candesartan or PBS basically ac-
cording to the method described previously [30] and then
Preparation and chemotaxis analysis of inflammatory sacrificed at six weeks after disease induction. Mesangial
leukocytes from nephritic glomeruli matrix expansion was scored as described previously.
To analyze the effect of AT1RA candesartan on theInflammatory leukocytes were isolated from glomeruli
of rats sacrificed on day 5 after 0.5 mg of mAb 1-22-3 expressions of fractalkine and CX3CR1, the prolonged
mesangial GN was induced in 12 rats as described above.injection following the method of Cook, Smith and Cat-
tell [29]. Glomerular leukocytes were resuspended at Six rats of each group were injected daily with candesar-
tan or PBS as described above, and then sacrificed on1  106/mL in MEM plus 10% heat-inactivated fetal
calf serum (FCS). Chemotaxis analysis was performed day 14 after disease induction. The expression of fractal-
kine and the recruitment of CX3CR1 cells were countedbasically according to the method described by Chen et al
[23]. In brief, 200 L of 107 mol/L human recombinant in 30 full sized glomeruli. For further analyses of mRNA
expressions of chemokines and renal function, the pro-fractalkine (Genzyme/Techne, Cambridge, MA, USA)
diluted with PBS with 1 mg/mL BSA was placed in the longed mesangial GN was induced in 10 rats. Five rats
each were injected with candesartan, or PBS and thenlower well of the blind well chamber, model BW 200S
(Neuro Probe, Inc., Cabin John, MD, USA), and sepa- sacrificed on day 14 after disease induction. Glomerular
RNA was prepared from pooled kidney of each group.rated from 200 L of cell suspension by an 5-m pore
size polyvinylpyrolidone-free polycarbonate filter (Neuro mRNA expressions for fractalkine, CX3CR1, MCP-1 and
MDC were analyzed by semiquantitative RT-PCR. Glo-Probe, Inc). After incubation at 37C for two hours,
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Table 2. Kidney bound mAb1-22-3, complement fixation, and mesangiolysis score
Kidney bound mAb1-22-3 C3 fluorescence Mesangiolysis score
Group lg/kidney (N 	 3) intensity seconds (N 	 5) (N 	 5)
Uninephrectomized 11.291.63 15.463.51 2.750.96
Sham operated 8.551.87 12.43.40 20
The C3 fluorescence intensity in glomeruli was expressed as the autoexposure time that was considered to reciprocally reflect the staining intensity.
merular mRNA expression of fractalkine was also ana-
lyzed by the real-time RT-PCR method. Systolic blood
pressure (SBP) was measured in conscious, restrained
rats using a tail-cuff sphyngmanometer on day 11 after
disease induction. Serum levels of creatinine were mea-
sured on day 14 according to the standard method. Creat-
inine clearance (CCr) was calculated from a urine sample
taken 24 hours before the animal was sacrificed.
Expression of fractalkine and CX3CR1 in the
prolonged model induced by two consecutive
injections of 1-22-3
To investigate the expression in another prolonged
model, the prolonged mesangial alterations were in-
duced by two consecutive injections of 1.0 mL of saline
containing 0.5 mg of mAb 1-22-3 twice an interval of two
weeks as already reported [31]. As control, the reversible
mesangial alteration was induced by injecting once with
0.5 mg of the mAb 1-22-3. The rats of each group were
sacrificed 30 minutes, 24 hours, 5, and 14 days after the
last injection. Glomerular mRNA expressions of fractal-
kine and CX3CR1 were examined by RT-PCR.
Statistical analysis
Statistical significance was evaluated using the un-
paired t test or the Mann-Whitney U test. All values
were expressed as the mean  SD. Differences at P 
 Fig. 1. (A) Time course of urinary protein excretion after monoclonal
antibody (mAb) 1-22-3 injection. The amount of 24-hour proteinuria0.05 were considered significant. Data were analyzed
was measured 1, 7 and 14 days after the surgery and 1, 3, 5, 7, 14, 21,using StatView for Macintosh (Abacus Concepts, Berke-
28, 35, 42, 48, and 56 days after the mAb 1-22-3 or PBS injection.
ley, CA, USA). Symbols are: () uninephrectomy  1-22-3; () sham operation 
1-22-3; () uninephrectomy  PBS. Abnormal proteinuria persisted
for 2 months in the uninephrectomized group, whereas urinary protein
excretion in the sham operated group was normalized by the 28th dayRESULTS
after mAb 1-22-3 injection. No abnormal proteinuria was detected in
Initiation events, urinary protein excretion and the uninephrectomized rats without injection of mAb 1-22-3. (B) Matrix
score, collagen type I score, and -SMA score in the uninephrectomizedmesangial alterations of the uninephrectomized
and sham operated groups. Symbols are: () uninephrectomy  1-22-prolonged model 3; () sham operation  1-22-3; ( ) uninephrectomy  PBS; *P 

0.05; **P 
 0.01; ***P 
 0.005. The mesangial matrix expansion and theThe amount of kidney binding mAb 1-22-3, C3 fluo-
extension of SMA and collagen type I staining on the 56th day wasrescent intensity and the mesangiolysis score of uni- higher in the uninephrectomized group than in the sham operated group.
nephrectomized and sham operated groups were summa-
rized in Table 2. There was no statistically significant
difference in the intensity of the C3 deposition and the
tween both groups. Although urinary protein excretionmesangiolysis score in both groups. The kinetics of uri-
of the sham operated group decreased gradually andnary protein excretion was shown in Figure 1A. The
normalized by four weeks after the injection, abnormalamount of urinary protein excretion peaked on day 3
after injection in both groups. No difference of the proteinuria persisted for two months in the uninephrec-
tomized group. No abnormal proteinuria was detectedamount of proteinuria on days 5 and 7 was detected be-
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Fig. 2. Light micrographs (A, C, E ) and immunofluorescence micro-
graphs of anti-type I collagen (B, D, F ) on the 56th day after mAb
1-22-3. Mesangial cell proliferation and severe matrix expansion are
still detected on the 56th day after mAb 1-22-3 injection in uninephrec-
tomized rats (A), whereas LM findings of sham operated rats were Fig. 3. Time course of the number of infiltrating inflammatory cells in
almost normalized (C). Intense staining of collagen type I was detected glomeruli after injection of mAb 1-22-3 in the uninephrectomized group
in the mesangial area in uninephrectomized rats injected with mAb and the sham operated group. Symbols are: () uninephrectomized
1-22-3 (B). The staining of collagen type I in sham operated rats was prolonged model; () sham-operated reversible model; *P 
 0.05,
weak and focal (D). (E) and (F) show the control findings of uninephrec- **P
 0.01, ***P
 0.005 vs. corresponding time point of sham operated
tomized rats without injection of mAb 1-22-3 (A, C, E 200, B, D, F model. OX-1 cells in glomeruli increased in both groups, peaked at
400). 30 minutes and decreased gradually. (A) A larger number of OX-1
cells were detected on the 14th day in the uninephrectomized group
than that of the sham operated group. (B) RP-3 cells infiltration into
glomeruli peaked within 30 minutes. No significant difference of the
infiltration of RP-3 cells was detected in both groups. (C) In thein the uninephrectomized rats without an injection of
uninephrectomized group, ED1 cells infiltrated into glomeruli earlier
mAb 1-22-3 during the experimental period. No differ- than in the sham operated group. (D) Increased number of ED3 cells
ence of mesangial alteration on day 5 was observed be- in glomeruli was detected on the 5th day and the 14th day in both
groups. The number of ED3 cells in the uninephrectomized grouptween both groups. In the sham operated group, al-
was larger than that of the sham-operated group. (E) Few of OX-19
though mesangial morphological alterations were still cells were detected in both groups.
detected on the 14th day, mesangial alterations were
gradually decreased by the 56th day. Severe mesangial
alterations were still detected on the 56th day in the
collagen type I IF staining on the 56th day after injectionuninephrectomized group. The mesangial matrix score
are shown in Figure 2. These results support the previousand the IF intensity scores of -SMA, and collagen type
report that the mesangial alteration induced by mAbI on the 56th day were shown in Figure 1B. Mesangial
1-22-3 injection into uninephrectomized rats are pro-matrix expansion in the uninephrectomized group was
longed.3.85 times higher than that of the sham operated group.
The IF intensity score of -SMA and the collagen type
Infiltration of inflammatory cells in glomeruliI of the uninephrectomized group was 2.01, and 1.93
The kinetics of the recruitment of OX-1, RP-3,times higher than those of the sham group. No abnormal
ED1, ED3, and OX-19 cells were shown in Figuremorphological alterations were observed in the uni-
3. OX-1 cells in glomeruli increased in both groups,nephrectomized rats without injection of mAb 1-22-3.
The representative findings of the light microscopy and peaked at 30 minutes after mAb 1-22-3 injection and
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decreased gradually. A larger number of OX-1 cells
were detected on the 14th day in the uninephrectomized
group than in the sham operated group (Fig. 3A). RP-3
cells accumulated rapidly, peaked at 30 minutes after
the injection of mAb 1-22-3, and had returned to normal
levels by day 5. No significant difference of the infiltra-
tion of RP-3 cells was observed in both groups (Fig.
3B). In the uninephrectomized group, ED1 cells infil-
trated into glomeruli earlier than in the sham operated
group. However, no difference of the peak number of
ED1 cells was observed in both groups (Fig. 3C). Few
of ED3 cells were detected in normal glomeruli and at
the early stage of the 1-22-3 induced glomerulonephritis,
but the number of ED3 cells increased at the later stage
(days 5 and 14) in both groups. The number of ED3
cells recruited in glomeruli in the uninephrectomized
group was already significantly higher on day 5 than that
of the sham operated rats (P 
 0.05). The number of
ED3 cells on the 14th day was 4.5 times higher in the
uninephrectomized group than in the sham operated
group (Fig. 3D). Few of OX-19 cells were detected in
both groups (Fig. 3E).
mRNA expression for chemokines in glomeruli
mRNA expression of MCP-1 in the uninephrectom-
ized group was already increased at 30 minutes (2.70
times to the normal expression) and decreased to 1.33
times at 24 hours, whereas MCP-1 mRNA expression in
the sham operated group at 30 minutes is 1.99 times to
the normal expression and peaked at 24 hours (2.62
times). Increased mRNA expression of the lymphotactin
was detected on the fifth day in both groups. There was
no significant difference of lymphotactin expression on
day 5 between the uninephrectomized group (2.26 times
to normal expression) and the sham operated group (2.32
times). Increased mRNA expression of the TARC was
detected on the 14th day in both groups, and there was
no significant difference between the uninephrectomized
group (1.85 times to normal expression) and the sham
operated group (1.45 times). No increased expression of
RANTES was detected in both groups at any time points
Fig. 4. Kinetics of fractalkine (FKN) and CX3CR1 mRNA expressionexamined. In the uninephrectomized group, mRNA ex- on the 14th day after mAb 1-22-3 injection. (A) mRNA expression was
pression of the fractalkine dramatically increased on the semiquantitated by RT-PCR using cDNA corresponding to 750 ng
RNA. Symbols are: () nephrectomized; () sham-operated. The opti-14th day (6.5 times to normal expression). The fractal-
mal cycle numbers were determined in a preliminary trial to be in thekine expression of the uninephrectomized group was linear phase of amplification. Ratios of the densitometric signals of
significantly higher than that in the sham operated group FKN (left panel) or CX3CR1 (right panel) and the internal control
(GAPDH) were analyzed. The data are shown as the ratio relative to(2.5 times to sham operated group). The kinetics of the
normal rat findings and are expressed as mean  SD of three indepen-expression of fractalkine and a representative RT-PCR dent experiments. FKN mRNA expression of uninephrectomized rats
finding on the 14th day is shown in Figure 4. on day 14 was 2.52 times higher than that in the normal rat findings. (B)
Representative agarose gel electrophoretic patterns of PCR products of
FKN, CX3CR1, and GAPDH on day 14 in 3 cycle intervals.Immunostaining of fractalkine
In the uninephrectomized group, clearly positive stain-
ing of fractalkine in glomeruli was already detected at
24 hours, and its intensity peaked on the 14th day (Fig.
5A). No positive staining of fractalkine was detected on
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Fig. 5. Immunofluorescence findings of fractalkine (FKN) and CX3CR1 in glomeruli after mAb 1-22-3 injection in the uninephrectomized rat.
(A) Immunofluorescence micrograph of FKN on the 14th day after mAb 1-22-3 injection into a uninephrectomized rat. Intense staining of FKN
is detected at the site facing the capillary lumen (arrowheads), and the staining is also detected at the mesangial area (arrows). (B) No staining
is detected with anti-FKN antibody (Ab) pre-incubated with fusion protein of the extracellular site of FKN in the same rat material as used in
panel A. (C ) FKN staining is not detected in normal rat glomeruli. (D) Dual labeling staining with anti-FKN Ab (green) and anti-RECA1 Ab
(red) on the 5th day. A part of RECA1 positive cells (endothelial cells) is positive for FKN (yellow). (E ) Dual labeling staining with anti-FKN
Ab (green) and anti-RECA1 Ab (red) on the 14th day. Positive staining of FKN is detected in endothelial cell (yellow, arrow head) and in the
mesangial area (green). (F ) Dual labeling staining with anti-FKN Ab (green) and mAb 1-22-3 (red) on the 14th day. Monoclonal antibody (mAb)
1-22-3 was used as a marker for mesangial cell. Positive staining of FKN is detected in the mesangial area (yellow). (G ) Dual labeling staining
with anti-CX3CR1 (green) and with ED1 (red) on the 5th day. A part of the ED1 cells are also stained with anti-CX3CR1 (yellow, arrows). (H )
Dual labeling staining with anti-CX3CR1 (green) and with ED3 (red) on the 5th day. Major parts of ED3 cells are also stained with anti-CX3CR1
(yellow, arrows). (I) Dual labeling staining with anti-CX3CR1 (green) and with OX-19 (red) on the 5th day. No double positive cells were detected.
the 56th day in the uninephrectomized group. Fractal- 5C). On the fifth day, a part of the endothelial cells was
positive for fractalkine (Fig. 5D), and fractalkine expres-kine staining in the sham operated group was weak and
focal at the any of the time points examined. Fractalkine sion also was detected in the mesangial area on the 14th
day (Fig. 5 E, F). No positive staining was detected withexpression was not detected in the normal kidneys (Fig.
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Fig. 6. Time course of number of CX3CR1
positive cells and double positive cells co-
stained with (A) ED1, (B) ED3, or (C ) OX-19.
Symbols are the numbers of: CX3CR1-positive
cells in the () uninephrectomized group and
( ) sham operated group; () double positive
cells with CX3CR1 and each macrophage and
T cell marker. *P 
 0.05, #P 
 0.005. Infiltra-
tion of CX3CR1 cells in glomeruli peaked on
the 5th day after injection of mAb 1-22-3. The
number of CX3CR1 cells was larger in the
uninephrectomized group than in the sham
operated group. The majority of the CX3CR1
cells were positive for macrophage marker.
Almost all CX3CR1 cells were negative for
T cell marker.
anti-fractalkine antibody that was pre-absorbed with fu-
sion protein of chemotactic site of fractalkine (Fig. 5B),
although positive staining was detected with anti-fractal-
kine antibody that was preincubated with fusion protein
of pGEX-6P-1 without insert. The rate of fractalkine
positive glomeruli was significantly higher in the uni-
nephrectomized group than in the sham operated group
(60  17 vs. 18  13%, P 
 0.01).
mRNA expression of CX3CR1 and identification of
CX3CR1 expressing cells
Increased mRNA expression of CX3CR1 was already
detected at 24 hours in the uninephrectomized group.
The CX3CR1 mRNA expression in the uninephrectom-
ized group on the 14th day was significantly higher than
that in the sham operated group. The kinetics of the
expression of CX3CR1 and a representative RT-PCR
finding on the 14th day is shown in Figure 4. The expres-
sion of CX3CR1 mRNA was decreased to almost normal
Fig. 7. Chemotaxis of glomerular leukocytes to fractalkine (FKN).level on 56th day. The dual labeling of the immunofluo- Chemotaxis of inflammatory leukocytes isolated from glomeruli of rats
rescence findings of the anti-CX3CR1 with ED1, ED3, injected with mAb 1-22-3 to FKN was assayed. The mean numbers of
migratory cells per low power field (200) on the undersurface of theor OX-19 is shown in Figure 5 (G-I), and the kinetics
filter were shown (A). The representative Giemsa staining specimens
of the double positive cells of CX3CR1 and ED1, ED3, of the inflammatory leukocytes migrated to undersurface of the filter
of the chamber with FKN (B), and of the chamber with PBS/BSA onlyor OX-19 is in Figure 6. The number of CX3CR1 cells in
(C ). (D) Immunofluorescence finding of the filter with ED3 shows thatglomeruli peaked on the fifth day and were significantly
ED3 cells were attracted by FKN (B, C 200; D 400).
increased in the uninephrectomized group (1.42 times
more to the number of sham operated groups on day
5). The majority of the CX3CR1 cell was positive for
macrophage marker: 66.7% of the CX3CR1 cells were shown in Figure 7A. The representative finding of Giemsa
ED3 cells on the fifth day and 73.9% on the 14th day staining specimens of the cells attracted by fractalkine
in the prolonged model. On the other hand, 69.5% of and the finding of negative control with PBS/BSA were
ED3 macrophages in glomeruli on the fifth day in the shown in Figure 7 B and C, respectively. Figure 7D shows
prolonged model were positive for CX3CR1, and 80.7% that a part of leukocytes attracted by fractalkine was
on the 14th day. ED3 cells.
Effect of candesartan on the expression of fractalkineChemotaxis analysis of inflammatory leukocytes from
nephritic glomeruli and the recruitment of CX3CR1 cells
We confirmed that the candesartan treatment amelio-The mean numbers of leukocytes on the undersurface
of the filter attracted by fractalkine or PBS/BSA were rated the matrix score at six weeks after disease induction
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DISCUSSION
We previously reported that a single injection of anti-
Thy 1 mAb 1-22-3 [32, 33] into the uninephrectomized
rats was capable of inducing the persistent proteinuria
and the prolonged mesangial alterations (prolonged
model) [18, 30], although the mesangial alterations in-
duced by a single injection of mAb 1-22-3 to normal rats
without uninephrectomy were reversible (reversible
model) [32]. While the hemodynamic change caused byFig. 8. Comparison of fractalkine (FKN) expression and the recruit-
ment of CX3CR1 cells in the glomeruli between candesartan-treated a uninephrectomy is considered to affect the outcome of
(NxTx) and non-treated rats (Nx). The rate of FKN positive glomeruli the disease, the precise mechanism of the prolonged
(A) and the number of CX3CR1 cells in glomeruli (B) on the 14th day model has not been clarified yet. To compare the initia-after mAb 1-22-3 injection into uninephrectomized rats was determined.
FKN expression and the number of CX3CR1 cells in glomeruli were tion events just after mAb 1-22-3 injection and the conse-
significantly decreased by treatment with candesartan. quent inflammatory responses in the glomeruli between
the sham operated reversible model and the uninephrec-
tomized prolonged model is a successful way to identify
the essential factor in bringing about the prolonged alter-
(0.38  0.096 vs. 1.40  0.16 candesartan treatment vs.
ations.
PBS treatment, P 
 0.01). However, the candesartan First, the initiation events just after the mAb 1-22-3
treatment did not ameliorate the matrix score on day 14 injection were compared in these models. The amount
(1.22  0.133 vs. 1.23  0.068, candesartan treatment vs. of the kidney binding mAb 1-22-3 was higher in the
PBS treatment). There were no significant differences nephrectomized group than in the sham operated group
of CCr or serum creatinine on the 14th day between can- (11.3 vs. 8.55g/kidney; Table 1). However, our previous
desartan and PBS treated groups (candesartan treatment quantitative study with various injection doses of mAb
vs. PBS treatment, 4.20 0.59 vs. 4.38 0.35 mL/min/kg 1-22-3 showed that there was no significant difference
body wt; serum creatinine: 0.46  0.03 vs. 0.50  0.04 in the infiltrating cells and the severity of mesangial alter-
mg/dL; serum creatinine of normal rat findings: 0.29  ations between 0.5 mg injected rats (kidney binding, 7.2
0.05 mg/dL). Candesartan treatment did not decrease g/kidney) and 10 mg injected rats (kidney binding, 32.7
SBP on day 11 (112.64  49.1 vs. 128.94  24.21 mm Hg g/ kidney) [27]. We experienced that the prolonged
candesartan treatment vs. PBS treatment; SBP of normal mesangial alterations could be induced by a half dose of
rat, 129.22 12.2 mm Hg). By contrast, decreased immu- mAb 1-22-3 injection into uninephrectomized rats (data
not shown). We did not detect the significant differencesnostaining of fractalkine was observed in the candesartan
of the complement deposition and the severity of thetreated group on the 14th day (Fig. 8A). The number
mesangiolysis between the nephrectomized and the shamof CX3CR1 cells in the glomeruli of the candesartan
operated models (Table 2). These observations indicatetreated group on the 14th day was significantly less than
the difference of the kidney binding antibody betweenin the PBS treated group (Fig. 8B). Decreased mRNA
the sham operated and the uninephrectomized groupsexpressions of fractalkine and CX3CR1 were observed
had little effect on the different outcomes of the disease.in the candesartan treated group on the 14th day (Fig.
Next, we compared the expression of chemokine and9). Real-time RT-PCR analysis also showed that de-
the recruitment of inflammatory cells in glomeruli aftercreased expression of glomerular mRNA for fractalkine
mAb 1-22-3 injection in the sham operated reversiblein rats treated with candesartan. Although candesartan
model and the uninephrectomized prolonged model.treatment decreased mRNA expression of MDS, the de-
Fractalkine expression of the uninephrectomized groupcrease of MDC was not so remarkable if compared with
was significantly higher than that in the sham operated
the decrease of fractalkine (Fig. 9). Candesartan treat-
group, although no difference in the expressions for
ment increased mRNA expression of MCP-1 (Fig. 9). MCP-1, TARC, lymphotactin, or RANTES was de-
tected. The mRNA expression of the fractalkine on the
mRNA expression of fractalkine and CX3CR1 in 14th day of the uninephrectomized prolonged model was
mAb1-22-3 two consecutive injections model 2.5 times higher than that of the sham-operated revers-
In the two consecutive injections model, mRNA ex- ible model (Fig. 4). In addition, clear positive immuno-
pression of fractalkine and CX3CR1 in the glomeruli staining of fractalkine in glomeruli was detected in the
after the second injection was higher than those after the uninephrectomized prolonged model at 24 hours, whereas
first injection. The RT-PCR data on the 14th day after fractalkine staining in the sham-operated reversible
model was weak and focal at any time points examined.the first and second injections are shown in Figure 10.
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Fig. 9. Chemokines and CX3CR1 mRNA expression on the 14th day after mAb 1-22-3 injection with or without treatment of candesartan. mRNA
expression was semiquantitated by RT-PCR using cDNA corresponding to 750 ng RNA. The optimal cycle numbers were determined in a
preliminary trial to be in the linear phase of amplification. (A) The findings of candesartan treated group are shown in the upper panel, and those
of the nephritic control without treatment of candesartan (PBS injected group) are in the bottom panel. Representative agarose gel electrophoretic
patterns of PCR products of FKN, CX3CR1, MCP-1, MDC, and GAPDH in 3 cycle intervals are shown. (B) Ratios of the densitometric signals
of () FKN, ( ) CX3CR1, ( ) MCP-1 or ( ) MDC and the internal control (GAPDH) were analyzed. The data are shown as ratio relative to
PBS injected group and are expressed as mean  SD of three independent experiments. Candesatran treatment reduced the expression of FKN
and CX3CR1. By contrast, candesartan treatment increased MCP-1 mRNA expression. (C ) Real-time RT-PCR analysis of fractalkine in rats
treated with candesartan. The x-axis shows the number of PCR cycles, and the y-axis is the difference between measured fluorescence and the
baseline. Decreased expression of fractalkine in rats treated with candesartan was confirmed. Lines are: (a) GAPDH, PBS injection; (b) GAPDH
candesartan treated; (c) FKN, PBS injection; (d) FKN, candesartan-treated.
We also observed that mRNA expression of CX3CR1 mesangial alterations, the fractalkine expression was in-
vestigated in another prolonged model induced by two(Fig. 4) and the number of the recruited CX3CR1 cells
in glomeruli were much higher in the uninephrectomized consecutive injections of mAb 1-22-3 into rats without
pre-uninephrectomy. The expressions of fractalkine andmodel than in the sham operated model. We confirmed
that fractalkine was concerned with the recruitment of CX3CR1 after the second mAb 1-22-3 injection were
much higher than those after the first injection (Fig.leukocytes into glomeruli in mAb 1-22-3-induced ne-
phropathy by the chemotaxis experiment using the leu- 10). Together, these findings suggested that fractalkine
expression and the recruitment of CX3CR1 cells playkocytes prepared from glomeruli of rats injected with
mAb 1-22-3 (Fig. 7). To analyze whether the expression an important role on the development of the prolonged
glomerular alterations.of fractalkine and CX3CR1 is the unique finding in the
uninephrectomized prolonged model, or if they com- The reason that fractalkine expression is higher in
these prolonged models than in the reversible modelmonly participate in the development of the prolonged
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fractalkine. Whatever the mechanism, we believe that
the increased expression of fractalkine in the injured
glomeruli contributes to causing the prolonged glomeru-
lar alterations.
This study shows that AT1RA treatment ameliorated
the glomerular morphological findings at six weeks in
the nephrectomized prolonged model, although the
treatment did not ameliorate the glomerular morpholog-
ical findings at two weeks. We clearly demonstrated that
the immunostaining and mRNA expression of fractal-
kine and the number of CX3CR1 cells recruited in glo-
meruli were already decreased at two weeks after disease
induction in rats treated with AT1RA (Figs. 8 and 9).
These findings indicate that the expression of fractalkine/
CX3CR1 could be a predictor of the prolonged disease,
and suggest that fractalkine/CX3CR1 contributes to the
development of the glomerular alterations. Although the
precise therapeutic mechanism of AT1RA on protein-
uria and mesangial proliferation remains unclear [38–42],
it has been reported that AT1RA ameliorates the glo-
Fig. 10. Fractalkine (FKN) and CX3CR1 expression on the 14th day merular hypertension by relaxing the efferent micro-
after the first and the second mAb 1-22-3 injections. mRNA expression artery [42]. AT1RA did not influence the glomerularwas semiquantitated by RT-PCR using cDNA corresponding to 750 ng
alterations detected at two weeks after disease induction.RNA. The optimal cycle numbers were determined in a preliminary
trial to be in the linear phase of amplification. Ratios of the densitomet- The early stage of Thy 1 nephritis is characterized by
ric signals of FKN or CX3CR1 and the internal control (GAPDH) were the mesangiolysis caused by the binding of anti-Thy 1analyzed. The data are shown as ratio relative to normal rat findings
antibody and the consequent mesangial cell proliferationand are expressed as mean  SD of three independent experiments.
FKN and CX3CR1 mRNA expressions after the second mAb injection and the matrix expansion detected at two weeks. It is
are higher than those after the first injection. accepted that these alterations are self-limiting. These
glomerular alterations of the early stage were observed
similarly in both prolonged and the reversible models.
We consider that glomerular hypertension contributesremains unclear. However, the findings obtained in this
study give us a possible clue. Fractalkine is considered to the development of the prolonged glomerular alter-
ations. It is conceivable that AT1RA prevents the devel-to be important for leukocytes recruitment especially
in tissue with a high blood flow rate [34, 35], because opment of the prolonged alterations by reducing the
glomerular hypertension. Interestingly, we observed thefractalkine functions as both a chemoattractant and an
adhesion molecule for leukocytes [20, 21]. Feng et al increased MCP-1 expression in rats treated with
AT1RA. Stahl et al reported that MCP-1 is producedreported that fractalkine might play an important role
for the recruitment of leukocytes in glomeruli, because by mesangial cell in Thy 1 nephritis [43]. Our current
study shows that fractalkine also is produced by mesan-glomeruli have a high blood flow rate [22]. Because uni-
nephrectomy causes glomerular hypertension in the re- gial cells. The reason why AT1RA treatment increased
the expression of MCP-1 is not clear. However, thismaining kidney, it is conceivable that fractalkine might
play a more important role in the remaining kidney of might be explained by the following mechanism: In the
high shear environment, mesangial cells produce fractal-our nephrectomized model. Fractalkine was expressed
more actively under the condition with glomerular hy- kine more actively than MCP-1. The AT1RA treatment
might prevent this alternative response of the mesangialpertension for the development of inflammatory re-
sponses. In the prolonged model caused by the consecu- cell, which then would increase the MCP-1 expression.
Using dual-labeled IF studies, the localization of frac-tive injections of mAb 1-22-3, the locally increased blood
pressure in the glomeruli—the structure of which was talkine was analyzed to determine the exact subpopula-
tions of the leukocyte containing the CX3CR1 cells.damaged by the first injection of mAb 1-22-3—might
be involved in the highly expression of fractalkine. Of Fractalkine was expressed by endothelial cells in the
early phase of the uninephrectomized model (Fig. 5D).course, another possibility cannot be ruled out. Two re-
cent reports have suggested that glomerular hyperten- Interestingly, fractalkine staining was detected not only
at the endothelial cells but also in the mesangial areasion is not essential for the development of prolonged
glomerular alterations [36, 37]. Another possibility is (Fig. 5 E, F) in the later phase of the prolonged model.
Dual labeling studies with markers of inflammatory cellsthat some cytokines act on mesangial cells to produce
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